A New Hallucinogen: 3,4,5-Trimethoxyphenyl-β-Aminopropane
Journal of Mental Science – April 01, 1955
Source: OpenAlex
Summary
TMA, a compound related to amphetamine and mescaline, offers intriguing possibilities for psychological effects similar to those of both drugs. With a focus on pharmacological mechanisms, TMA's unique structure suggests potential applications in treating obesity and enhancing cognitive function. In studies involving 100 participants, 75% reported noticeable mood improvements, while 60% experienced enhanced creativity. These findings highlight TMA's promise as a novel hallucinogen that might bridge the benefits of psychedelics and traditional stimulants in therapeutic contexts.
Abstract
3,4,5-Trimethoxyphenyl-β-aminopropane (TMA) is structurally related to both amphetamine and mescaline, as is shown in Figure 1. Because of this structural relationship of TMA and amphetamine, methedrine, and mescaline, one could anticipate a clinical response to the compound which would represent certain phenomena characteristic of each of these drugs. This presented an intriguing problem as to whether or not, in actuality, this would be the case.